Stay updated on Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial
Sign up to get notified when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.

Latest updates to the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, reflecting a minor platform update rather than changes to user-facing content.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.6.4 is now shown in the page footer, replacing the previous v3.6.3. This reflects a minor version update to the site's interface rather than changes to the study data.SummaryDifference0.0%

- Check44 days agoChange DetectedThe website now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating an update to the page's revision identifier rather than to study data or content.SummaryDifference0.0%

- Check51 days agoChange DetectedAn updated software build identifier (v3.6.2) is now displayed on the page, replacing the previous v3.6.0. This appears to be routine page maintenance and does not modify the study information or visible content.SummaryDifference0.0%

- Check65 days agoChange DetectedRecruitment status is updated to No longer looking for participants, reflecting that participant enrollment has ended. The page also adds new user-facing sections (How to Read a Study Record, Common Questions, How to Join a Study), reformats the Intervention/Treatment heading, and lists Revision: v3.6.0 as the current version.SummaryDifference0.3%

- Check72 days agoChange DetectedThe page's revision label was updated to v3.5.5, representing a minor version update to the page. This does not modify the study details or visible content.SummaryDifference0.0%

Stay in the know with updates to Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.